AMPHENOL CORPORATION (APH) — financial distillation
Annual history (10-K)
Quarterly history (10-Q)
Two headline lines are shown to start. Click any item in a legend to add or remove it — every figure on the chart is one the table below also carries, for the period it names.
In brief, from the full filed history
- Revenue grew from $2.85B (period ending 2007-12-31) to $23.09B (period ending 2025-12-31) — a 12.3% annual pace across 18 year(s) of filed history.
- Net margin expanded from 12.4% to 18.5% over that same span.
- Across 55 tracked quarters, the strongest was $8.76B (quarter ending 2026-06-30) and the weakest was $660.0M (quarter ending 2009-03-31).
Annual — most recent 10-K
| Line | Value | Period ends | Form | Filing |
|---|---|---|---|---|
| Revenue | $23.09B | 2025-12-31 | 10-K | 0001104659-26-013549 |
| Gross profit | $8.52B | 2025-12-31 | 10-K | 0001104659-26-013549 |
| Operating income | $5.87B | 2025-12-31 | 10-K | 0001104659-26-013549 |
| Net income | $4.27B | 2025-12-31 | 10-K | 0001104659-26-013549 |
| Diluted EPS | $3.34 | 2025-12-31 | 10-K | 0001104659-26-013549 |
| Total assets | $36.24B | 2025-12-31 | 10-K | 0001104659-26-013549 |
| Total liabilities | $22.73B | 2025-12-31 | 10-K | 0001104659-26-013549 |
| Cash & equivalents | $11.13B | 2025-12-31 | 10-K | 0001104659-26-013549 |
| Operating cash flow | $5.37B | 2025-12-31 | 10-K | 0001104659-26-013549 |
Quarterly — most recent 10-Q
| Line | Value | Period ends | Form | Filing |
|---|---|---|---|---|
| Revenue | $8.76B | 2026-06-30 | 10-Q | 0001104659-26-089194 |
| Gross profit | $3.55B | 2026-06-30 | 10-Q | 0001104659-26-089194 |
| Operating income | $2.58B | 2026-06-30 | 10-Q | 0001104659-26-089194 |
| Net income | $1.77B | 2026-06-30 | 10-Q | 0001104659-26-089194 |
| Diluted EPS | $1.37 | 2026-06-30 | 10-Q | 0001104659-26-089194 |
| Total assets | $44.81B | 2026-06-30 | 10-Q | 0001104659-26-089194 |
| Total liabilities | $29.18B | 2026-06-30 | 10-Q | 0001104659-26-089194 |
| Cash & equivalents | $4.73B | 2026-06-30 | 10-Q | 0001104659-26-089194 |
| Operating cash flow | $1.12B | 2026-03-31 | 10-Q | 0001104659-26-054128 |
Reading
The figures above are taken directly from filings with the U.S. Securities and Exchange Commission. The reading below was generated by a local language model from only those figures; it introduces no numbers of its own. It is not investment advice.
Amphenol Corporation’s financial landscape is characterized by substantial scale and a robust, consistently growing business. The company’s revenue has escalated from $2.85 billion in 2007 to a staggering $23.09 billion in 2025, reflecting an impressive compound annual growth rate (CAGR) of 12.3% over an 18-year period. This growth trajectory underscores the company’s successful expansion and market penetration.
The financial health is further evidenced by a net margin that has expanded from 12.4% to 18.5% during this timeframe, indicating enhanced profitability and operational efficiency. Amphenol’s quarterly revenue performance reveals a peak of $8.76 billion in the second quarter of 2026, while the lowest recorded was $660 million in the first quarter of 2009, highlighting seasonal fluctuations and broader economic influences on its business.
In examining future filings, investors should focus on Amphenol’s ability to sustain this growth trajectory amidst potential market saturation or increased competition. Additionally, monitoring the company’s asset management, particularly in light of increasing total liabilities and fluctuating cash reserves, will be crucial for assessing its financial stability and strategic capital allocation decisions.
Source: SEC EDGAR company facts for CIK 0000820313 · filings index